GlassScriptPhysician profile
April Mccain
NPI 1043685498
$1,579.31
in general payments reported to CMS, 2019-2025
15 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $110 · 2022: $211 · 2023: $229 · 2024: $565 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.31 | 2022-2025 | |
| Kerecis Limited | $233.60 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| La Jolla Pharmaceutical Company | $217.57 | 2021-2023 | Xerava, Xacduro |
| Smith+Nephew, INC. | $148.03 | 2023-2025 | Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $123.98 | 2024-2025 | Nuzyra |
| Merck Sharp & Dohme LLC | $104.72 | 2022-2023 | Zerbaxa, Recarbrio, Dificid |
| Mimedx Group, INC. | $100.81 | 2024-2025 | |
| Convatec INC. | $84.08 | 2024 | |
| Organogenesis INC. | $49.89 | 2023-2024 | Apligraf, Puraply |
| Cumberland Pharmaceuticals, INC. | $41.98 | 2022 | |
| Viiv Healthcare Company | $28.90 | 2021 | |
| Reapplix INC. | $17.80 | 2024 | 3c Patch Kit - Box |
| Solventum Corporation | $17.58 | 2024 | Activ.A.C. |
| Hartmann USA, INC. | $16.39 | 2024 | Zetuvit Plus 10x10 P10 |
| Theratechnologies INC. | $14.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Mccain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.